RE:RE:RE:RE:RE:INVESTORS ARENT BUYING IT YETThe FDA granting approval or not based in trust vs data on an oncology drug. Hokding back now because of some half baked whiney complaint of many years ago for cold laser therapy claims....probably generated by a competitor looking to delay the inevitable success of Theralase. Is insane to consider. Would it then be your supposition that were RDW a trusted CEO and just a better all around person in the eyes of the FDA (which had nothing to do with said complaint...that was the OSC). That the FDA would ignore data or maybe just fill in some blanks...and just trust a good guy that what he says his drug can do is gospel....yknow....cuz that's how oncology drug approvals work! Sure. Totally reasonable.